The European antiinfective medicine market in 2023 was led by Italy with sales of 40.6 million euros, despite a decline of 1.91% compared to 2022. Spain followed with 28.15 million euros, showing a slight dip of 0.34%. Greece and Belgium observed positive growths of 1.81% and 1.2% respectively. On the other hand, Austria's market contracted by 2.54%, and Ireland saw a shrinkage of 2.78%, among others. Luxembourg experienced notable expansion with an 11.42% increase, albeit from a smaller base of 0.26 million euros.
Looking ahead, future trends in the European antiinfective market could be influenced by innovations in infection treatment, potential changes in healthcare policies, and shifts in disease prevalence. Monitoring these factors could help anticipate further market dynamics.
- Italy: Slight decrease in sales shares.
- Spain: Minimal variation, maintaining a strong position.
- Greece & Belgium: Positive growth trajectory observed.
- Austria & Ireland: Notable contractions affecting market share.
- Luxembourg: Significant growth albeit from a small base.
Top countries in Antiinfective Medicine Sales Share by Country (Million Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 40.6 | 2023 | +1.82% | -1.91% | View data |
| 2 | 2 Spain | 28.15 | 2023 | +3.2% | -0.34% | View data |
| 3 | 3 Greece | 11.49 | 2023 | +1.92% | +1.81% | View data |
| 4 | 4 Belgium | 10.38 | 2023 | -0.015% | +1.2% | View data |
| 5 | 5 Austria | 3.33 | 2023 | +3.32% | -2.54% | View data |
| 6 | 6 Slovakia | 2.03 | 2023 | +1.45% | +2.57% | View data |
| 7 | 7 Portugal | 1.72 | 2023 | -5.39% | -1.53% | View data |
| 8 | 8 Ireland | 1.63 | 2023 | +7.58% | -2.78% | View data |
| 9 | 9 Slovenia | 0.4 | 2023 | +1.16% | -2.42% | View data |
| 10 | 10 Luxembourg | 0.26 | 2023 | +1.8% | +11.42% | View data |
